On 7 February, Verizon Communications Inc. (NYSE:VZ) announced its plans to sell off wire-line assets and tower operations worth over $10.5 billion, to Frontier Communications Corp (NASDAQ:FTR). On Friday shares of Verizon Communications Inc. (NYSE:VZ) closed at $49.33. Company’s sales growth for last 5 years was 3.30% and EPS growth for next 5 years is recorded as 7.88%.
On 26 January, Tesla Motors Inc (NASDAQ:TSLA) said that it plans to roll out the dual-motor version of its Model S in China in the coming months and hopes to release its Model X sport-utility vehicle there early next year. Tesla Motors Inc (NASDAQ:TSLA) in last trading activity decreased -1.64% to close at $217.36. Company weekly performance is 6.76% while its quarterly performance stands at -5.89%. Tesla Motors Inc (NASDAQ:TSLA) is -25.41% away from its 52 week high.
Hercules Offshore, Inc. (NASDAQ:HERO) announced that it has scheduled a conference call to discuss its fourth quarter and full year 2014 financial results on February 12, 2015. On last trading day Hercules Offshore, Inc. (NASDAQ:HERO) moved up 4.91% to close at $0.92. Its volatility for the week is 8.59% while volatility for the month is 8.89%. HERO’s sales growth for past 5 years was -5.00% and its EPS growth for past 5 years was 57.50%. Hercules Offshore, Inc. (NASDAQ:HERO) monthly performance is 9.90%.
On 4 February, Merck & Co. Inc. (NYSE:MRK) said the U.S. Food and Drug Administration intends to rescind its “breakthrough therapy” designation for its experimental combination treatment for hepatitis C because of other recently approved treatments. On last trading day Merck & Co. Inc. (NYSE:MRK) fell -0.64% to close at $58.79. Its volatility for the week is 2.02% while volatility for the month is 2.04%. MRK’s sales growth for past 5 years was 13.00% and its EPS growth for past 5 years was -16.50%. Merck & Co. Inc. (NYSE:MRK) monthly performance is -4.58%.
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) had its price target increased by RBC Capital from $477.00 to $480.00 in a research report sent to investors on Monday morning. The firm currently has an outperform rating on the stock. On last trading day Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) fell -1.69% to close at $406.86. Its volatility for the week is 3.37% while volatility for the month is 3.21%. REGN’s sales growth for past 5 years was 54.60% and its EPS growth for past 5 years was 42.20%. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) monthly performance is -0.21%.